1933 Industries Inc.

OTC: TGIFF · Healthcare · Drug Manufacturers - Specialty & Generic

Canadian filerHQ Vancouver, BCCIK 0001706145Reports USD

#1 of 1,418 Healthcare companies by revenue

EA Score

——

FH —DQ —GM —SS 52

v0.1 · 5/100 weight · pillars only

↑ Piotroski F, workforce scale · ↓ market scale, Altman-Z

Methodology →

Revenue TTM

$11.1M

Rev growth YoY (TTM)

-10.8%

Net income (FY)

—

Employees

as of 2026-08-25

Market cap

$2.3M

as of 2026-08-25

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

No filed financials — private or non-XBRL filer.

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

What is 1933 Industries Inc.’s financial profile?

1933 Industries Inc. has no structured financials on file — private or non-XBRL filer.

Peers · Healthcare

Endovia Health Sciences, Inc.——Artelo Biosciences, Inc.——Restart Life Sciences Corp.——Shuttle Pharmaceuticals Holdings, Inc.——Algernon Pharmaceuticals Inc.——Kelyniam Global, Inc.——

Key facts

CEOBrian Farrell

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

HeadquartersVancouver, BC

ExchangeOTC: TGIFF

Employees85

IPO date2013-05-22

Latest filings

No filings loaded.

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.